PRKAA2 and breast cancer: Consistently, overexpression of AMPK has been linked to a shorter metastasis‐free survival of breast cancer patients.[47] The authors confirmed their findings by knock‐down of PRKAA1 in 4T1 breast cancer cells which reduced the lung metastasis capabilities of the cells in vivo.